Paper20876809
Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
Ning BF and 11 others. Cancer Res, 2010. Cited by 214 papers, by iCite.
Cite this record
ConductScience Library. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Papers, record 20876809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20876809
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Hepatocyte Nuclear Factor 4 | Major topic |
| Liver Neoplasms | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Cell Nucleus | |
| Epithelial Cells | |
| Humans | |
| Immunohistochemistry | |
| Liver Cirrhosis | |
| Liver Neoplasms, Experimental | |
| Male | |
| Mesoderm | |
| Neoplastic Stem Cells | |
| Rats | |
| beta Catenin |
Source PubMed
Cited by134
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 214 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42318058 | Ligand-dependent reprogramming of HNF4A expression and function suppresses multistep hepatocarcinogenesis. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/42318058 | PubMed |
| 42118585 | HNF4α controls growth, identity, and KRAS inhibitor response in invasive mucinous adenocarcinoma of the lung. | J Clin Invest | 2026 | https://conductscience.org/library/papers/42118585 | PubMed |
| 41961923 | Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity. | Sci Adv | 2026 | https://conductscience.org/library/papers/41961923 | PubMed |
| 41925866 | The role of HNF4α in adenocarcinoma. | Biochem Soc Trans | 2026 | https://conductscience.org/library/papers/41925866 | PubMed |
| 41892336 | Inflammation-Driven Downregulation of CYP2E1 Is Associated with Attenuated Diethylnitrosamine (DEN)-Induced Hepatocarcinogenesis. | Cells | 2026 | https://conductscience.org/library/papers/41892336 | PubMed |
| 41866549 | HNF4α-HKDC1 axis orchestrates a metabolic rewiring to promote migration and metastasis in advanced gastric cancer. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41866549 | PubMed |
| 41685142 | Blocking TRIM47-mediated HNF4α degradation suppresses hepatocellular carcinoma progression. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/41685142 | PubMed |
| 41595461 | HNF4α as a Master Regulator of Epigenetic Dynamics in Epithelial Cells. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/41595461 | PubMed |
| 41124076 | Targeting the hepatic circadian clock concomitant with tyrosine kinase inhibition reverses late-stage hepatocellular carcinoma. | Cell Rep | 2025 | https://conductscience.org/library/papers/41124076 | PubMed |
| 41053012 | Hypermethylation-mediated HNF4A silencing by Helicobacter pylori infection drives gastric cancer by disrupting epithelial cell polarity and activating EMT signaling. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/41053012 | PubMed |
| 40615636 | Differentiation therapy with hepatocyte nuclear factor 4α for patients with hepatocellular carcinoma. | Cell Res | 2025 | https://conductscience.org/library/papers/40615636 | PubMed |
| 40512440 | Research progress on cancer-related epigenetic switches. | Invest New Drugs | 2025 | https://conductscience.org/library/papers/40512440 | PubMed |
| 40502476 | MRI Imaging Biomarkers for Prognostication of Hepatocellular Carcinoma. | J Korean Soc Radiol | 2025 | https://conductscience.org/library/papers/40502476 | PubMed |
| 40427523 | HNF4α-Mediated LINC02560 Promotes Papillary Thyroid Carcinoma Progression by Targeting the miR-505-5p/PDE4C Axis. | Biomolecules | 2025 | https://conductscience.org/library/papers/40427523 | PubMed |
| 40421114 | Innovative applications of silicon dioxide nanoparticles for targeted liver cancer treatment. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/40421114 | PubMed |
| 40392499 | Hepatocyte nuclear factor 4-Alpha: a key regulator in liver carcinogenesis. | Cell Oncol (Dordr) | 2025 | https://conductscience.org/library/papers/40392499 | PubMed |
| 40055119 | Acetylation: a new target for protein degradation in cancer. | Trends Cancer | 2025 | https://conductscience.org/library/papers/40055119 | PubMed |
| 39899681 | Targeting FDFT1 Reduces Cholesterol and Bile Acid Production and Delays Hepatocellular Carcinoma Progression Through the HNF4A/ALDOB/AKT1 Axis. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/39899681 | PubMed |
| 39638897 | Cell-permeated peptide P-T3H2 inhibits malignancy on hepatocellular carcinoma through stabilizing HNF4α protein. | Discov Oncol | 2024 | https://conductscience.org/library/papers/39638897 | PubMed |
| 39261648 | A critical role for HNF4α in polymicrobial sepsis-associated metabolic reprogramming and death. | EMBO Mol Med | 2024 | https://conductscience.org/library/papers/39261648 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| HNF4A | 3172 | PubTator's text mining | https://conductscience.org/library/genes/3172 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20876809
GET https://conductscience.org/api/papers/v1/20876809/cited_by?page=2